Fund HoldingsKynam Capital Management, LP

Total Portfolio Value
$898.92M
Total Bought
$120.50M
Total Sold
$175.20M
Net Transaction
-$54.70M
Filing Period:
Securities
SharesValue ($K)
Q4 2023
Q1 2024
Change
Q4 2023
Q1 2024
Weight (%)
Change
VERTEX PHARMACEUTICALS INC(VRTX)(Put)0100,000+100,000041,801+41,801
NATERA INC(NTRA)2,400,0002,000,000-400,000150,336182,92020.35%+32,584
DYNAVAX TECHNOLOGIES CORP1,514,3834,239,780+2,725,39721,17152,6165.85%+31,445
COGENT BIOSCIENCES INC(COGT)5,854,7668,500,000+2,645,23434,42657,1206.35%+22,694
IRONWOOD PHARMACEUTICALS INC01,625,000+1,625,000014,1541.57%+14,154
SYNDAX PHARMACEUTICALS INC(SNDX)5,660,0005,660,0000122,313134,70814.99%+12,395
VERA THERAPEUTICS INC(VERA)3,650,3391,526,787-2,123,55256,14265,8357.32%+9,693
2SEVENTY BIO INC5,953,8255,953,825025,42331,8533.54%+6,430
BIOCRYST PHARMACEUTICALS INC(BCRX)4,600,0006,527,491+1,927,49127,55433,1603.69%+5,606
WAVE LIFE SCIENCES LTD(WVE)3,932,0823,932,082019,85724,2612.70%+4,404
TYRA BIOSCIENCES INC(TYRA)340,190515,190+175,0004,7128,4490.94%+3,737
SUTRO BIOPHARMA INC2,001,7272,001,72708,58711,3101.26%+2,722
CELLDEX THERAPEUTICS INC NEW(CLDX)3,005,9042,900,000-105,904119,214121,71313.54%+2,499
LIQUIDIA CORPORATION(LQDA)2,698,3242,248,324-450,00032,46133,1633.69%+702
AMARIN CORP PLC12,022,95712,022,957010,46010,7101.19%+250
CARIBOU BIOSCIENCES INC1,068,5271,068,52706,1235,4920.61%-630
BURNING ROCK BIOTECH LTD8,694,4269,640,914+946,4888,0867,0200.78%-1,066
TRAVERE THERAPEUTICS INC(TVTX)2,000,0002,000,000017,98015,4201.72%-2,560
CENTESSA PHARMACEUTICALS PLC442,7040-442,7043,5240-3,524
CORCEPT THERAPEUTICS INC(CORT)(Put)585,900585,900019,03014,759-4,271
ACELYRIN INC1,200,000396,379-803,6218,9522,6760.30%-6,276
VIRIDIAN THERAPEUTICS INC(VRDN)607,915133,877-474,03813,2402,3440.26%-10,896
VAXCYTE INC(PCVX)1,002,407745,000-257,40762,95150,8915.66%-12,060
PROTAGONIST THERAPEUTICS INC2,004,8751,144,242-860,63345,97233,1033.68%-12,869
MORPHOSYS AG4,234,6850-4,234,68541,9230-41,923
IMMUNOGEN INC1,422,5030-1,422,50342,1770-42,177
Page 1 of 1